Lanxess (ETR:LXS) Given a €61.00 Price Target at Goldman Sachs Group

Share on StockTwits

Goldman Sachs Group set a €61.00 ($70.93) price objective on Lanxess (ETR:LXS) in a research note issued to investors on Wednesday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

Several other equities research analysts have also recently commented on LXS. Berenberg Bank set a €55.00 ($63.95) price target on Lanxess and gave the company a neutral rating in a report on Wednesday, September 25th. Barclays set a €57.00 ($66.28) price target on Lanxess and gave the company a neutral rating in a report on Thursday, September 26th. Independent Research set a €59.00 ($68.60) price target on Lanxess and gave the company a neutral rating in a report on Monday, August 12th. Warburg Research set a €77.30 ($89.88) price target on Lanxess and gave the company a buy rating in a report on Thursday, August 15th. Finally, HSBC set a €84.00 ($97.67) price target on Lanxess and gave the company a buy rating in a report on Wednesday, September 18th. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have assigned a buy rating to the company. The stock presently has an average rating of Hold and a consensus target price of €59.85 ($69.59).

Shares of ETR LXS traded up €1.56 ($1.81) during midday trading on Wednesday, hitting €63.88 ($74.28). The stock had a trading volume of 435,735 shares, compared to its average volume of 312,027. The company has a market capitalization of $5.58 billion and a PE ratio of 16.22. The stock has a 50 day simple moving average of €58.75 and a 200-day simple moving average of €53.26. Lanxess has a 1 year low of €39.47 ($45.90) and a 1 year high of €64.00 ($74.42). The company has a quick ratio of 1.54, a current ratio of 2.70 and a debt-to-equity ratio of 102.70.

About Lanxess

LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.

Read More: Earnings Reports

Analyst Recommendations for Lanxess (ETR:LXS)

Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Insider Selling: Microsoft Co.  EVP Sells 35,000 Shares of Stock
Insider Selling: Microsoft Co. EVP Sells 35,000 Shares of Stock
Insider Selling: Fitbit Inc  CEO Sells 340,987 Shares of Stock
Insider Selling: Fitbit Inc CEO Sells 340,987 Shares of Stock
The Medicines  Hits New 12-Month High at $84.48
The Medicines Hits New 12-Month High at $84.48
Canasil Resources  Hits New 1-Year Low at $0.06
Canasil Resources Hits New 1-Year Low at $0.06
CardioComm Solutions  Hits New 12-Month Low at $0.04
CardioComm Solutions Hits New 12-Month Low at $0.04
Cascadero Copper  Sets New 12-Month Low at $0.01
Cascadero Copper Sets New 12-Month Low at $0.01


© 2006-2019 Ticker Report